GHK-Cu Canada 100mg

GHK-Cu Canada: 100mg research product

GHK-Cu Canada researchers can obtain this 100mg copper-tripeptide material for controlled, non-human laboratory and formulation research. The product is supplied in a 10 mL vial format. It is not approved by Health Canada for injection, ingestion, diagnosis, treatment, or application to humans or animals.

GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine. Researchers study its copper-binding chemistry and its reported activity in cell, tissue-remodelling, extracellular-matrix, antioxidant, and cosmetic-formulation models. Published findings describe research signals; they do not establish that this product is a medicine or guarantee a cosmetic or clinical result.

GHK-Cu 100mg product overview

Qualified researchers should review the label, lot identifier, available analytical documentation, and project-specific handling requirements before beginning work.

What is GHK-Cu?

GHK is a three-amino-acid sequence made from glycine, histidine, and lysine. When it binds copper(II), it forms GHK-Cu. The copper complex has distinct chemical properties from the unbound tripeptide, so researchers should not treat “GHK,” “GHK-Cu,” and every product marketed as a “copper peptide” as interchangeable.

GHK was first identified in human plasma, and later research examined GHK-Cu in biochemical, cellular, animal, and limited human cosmetic contexts. A peer-reviewed review indexed by PubMed summarizes reported tissue-remodelling, antioxidant, inflammatory-signalling, and regeneration research. However, evidence quality and relevance vary by model, formulation, concentration, delivery system, and outcome.

Why researchers study GHK-Cu

Extracellular-matrix research

Experimental literature has examined collagen, elastin, glycosaminoglycans, fibroblast activity, and matrix-remodelling enzymes. These findings help researchers explore how copper-binding peptides interact with tissue-remodelling pathways. They do not prove a result from an untested finished formulation.

Oxidative and inflammatory signalling

In-vitro and preclinical studies have reported changes in antioxidant and inflammation-related pathways. Because these are model-dependent observations, researchers should avoid turning them into unsupported treatment claims.

Skin and formulation research

GHK-Cu appears frequently in cosmetic-science literature. Still, raw research material differs from a finished cosmetic that has undergone stability, preservation, compatibility, safety, and performance testing. A 2025 review of GHK-Cu skin permeation also highlights formulation and delivery challenges.

Analytical and comparative work

Researchers may use GHK-Cu as a reference material when comparing copper complexes, studying copper binding, or evaluating analytical methods. Suitability depends on the experiment and the supporting batch documentation.

GHK-Cu, GHK and cosmetic copper peptides are not the same

• GHK: the copper-free glycyl-L-histidyl-L-lysine tripeptide.
• GHK-Cu: the tripeptide complexed with copper(II).
• Cosmetic copper peptide: a broad marketing term that may refer to GHK-Cu or another copper-containing ingredient inside a finished formulation.
• Research material: a laboratory product that has not been established as a finished cosmetic or authorized medicine.

For accurate research records, identify the exact chemical form instead of relying on the phrase “copper peptide.”

GHK-Cu Canada regulatory and safety context

Product status depends on intended use, claims, formulation, and authorization. Health Canada has identified unauthorized GHK-Cu powder marketed in health-product contexts. Researchers and consumers can review the official Health Canada GHK-Cu and BPC-157 notice. An RUO label does not make a product safe or authorized for personal use.

This Red Leaf product is offered only for non-human laboratory and formulation research. Anyone with a medical, dermatologic, or cosmetic-treatment question should consult an appropriately licensed professional and use products authorized for the intended purpose.

How to evaluate a GHK-Cu research product

1. Match the identity. Confirm that documents refer to GHK-Cu rather than copper-free GHK or another complex.
2. Match the lot. The vial identifier should correspond to the available batch document.
3. Separate identity from purity. A purity result alone does not prove that the material is the claimed molecule.
4. Review the analytical method. Check the method, test date, laboratory, and reported result.
5. Confirm the quantity and format. Record the nominal content and container supplied.
6. Follow project-specific storage requirements. Do not assume that instructions from another supplier or another chemical form apply.
7. Maintain chain-of-custody records. Record receipt, label condition, lot number, storage, preparation, and disposal.
8. Reject therapeutic promises. Marketing claims are not a substitute for analytical evidence or regulatory authorization.

Understanding a Certificate of Analysis

A useful COA connects a test result to a specific product and batch. Review the product name, lot number, test date, method, laboratory, and result. Chromatographic purity and mass-based identity answer different questions. Neither one alone proves sterility, clinical safety, efficacy, or suitability for human use.

Check the Red Leaf Certificates of Analysis page for available documentation. If the relevant lot is not posted, contact support before relying on a general or unmatched report.

Storage and laboratory handling

GHK-Cu handling requirements can depend on physical form, packaging, moisture, light exposure, temperature, and the planned method. Keep the original label and lot information, follow the product-specific documentation, and use an approved laboratory protocol. Avoid repeated environmental exposure and do not copy handling directions from an unrelated product listing.

Why source GHK-Cu from within Canada?

Domestic fulfilment may reduce border delays and simplify documentation questions, returns, and shipment tracking. However, “ships from Canada” does not establish chemical identity, purity, authorization, or research suitability. Evaluate batch evidence and supplier transparency independently from shipping speed.

Before ordering, review the Canadian shipping information, returns policy, and research-use disclaimer. For broader context, see the guide to research peptide sourcing in Canada.

GHK-Cu Canada bottom line

This 100mg GHK-Cu product is intended for controlled non-human research. A careful evaluation should distinguish GHK-Cu from GHK, connect the vial to meaningful batch documentation, preserve chain-of-custody records, and keep scientific observations separate from therapeutic or cosmetic promises.

Research information reviewed August 1, 2026. Not for human or animal use. No medical, dosing, injection, reconstitution, or treatment guidance is provided.